ATE330029T1 - Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease - Google Patents

Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease

Info

Publication number
ATE330029T1
ATE330029T1 AT98961367T AT98961367T ATE330029T1 AT E330029 T1 ATE330029 T1 AT E330029T1 AT 98961367 T AT98961367 T AT 98961367T AT 98961367 T AT98961367 T AT 98961367T AT E330029 T1 ATE330029 T1 AT E330029T1
Authority
AT
Austria
Prior art keywords
prediposition
determination
lung disease
protease gene
disease based
Prior art date
Application number
AT98961367T
Other languages
English (en)
Inventor
Hiroshi Eguchi
Kazuyoshi Yamaoka
Kenichi Masuda
Susumu Yasuoka
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE330029T1 publication Critical patent/ATE330029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98961367T 1997-12-16 1998-12-16 Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease ATE330029T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34649497 1997-12-16

Publications (1)

Publication Number Publication Date
ATE330029T1 true ATE330029T1 (de) 2006-07-15

Family

ID=18383814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961367T ATE330029T1 (de) 1997-12-16 1998-12-16 Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease

Country Status (11)

Country Link
US (1) US6346385B1 (de)
EP (1) EP1043406B1 (de)
JP (1) JP4031199B2 (de)
KR (1) KR100502523B1 (de)
CN (1) CN1222615C (de)
AT (1) ATE330029T1 (de)
AU (1) AU747991B2 (de)
CA (1) CA2315218C (de)
DE (1) DE69834949T8 (de)
ES (1) ES2263228T3 (de)
WO (1) WO1999031271A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018562A1 (en) * 2000-08-28 2002-03-07 Teijin Limited Airway-specific trypsin-like enzymes and method of using the same
US20030170630A1 (en) * 2000-12-21 2003-09-11 Alsobrook John P. Proteins and nucleic acids encoding same
US6596489B2 (en) 2001-03-30 2003-07-22 Applied Gene Technologies Methods and compositions for analyzing nucleotide sequence mismatches using RNase H
GB0113266D0 (en) * 2001-05-31 2001-07-25 Bayer Ag Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease
DE60218162T2 (de) * 2001-06-05 2007-10-31 Auckland Uniservices Ltd. Verfahren und Zusammensetzungen zur Beurteilung der Lungenfunktion und von Lungenerkrankungen
AU2002364945A1 (en) * 2001-10-25 2003-07-09 Neurogenetics, Inc. Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
US20030224380A1 (en) * 2001-10-25 2003-12-04 The General Hospital Corporation Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge
CA2608142A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
US8076065B2 (en) * 2005-05-19 2011-12-13 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
ES2437240B1 (es) * 2012-06-05 2014-10-16 Servicio Andaluz De Salud Método de obtención de datos útiles para el diagnóstico, pronóstico y clasificación de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) y/o cáncer de pulmón

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2839825B2 (ja) 1993-08-30 1998-12-16 帝人株式会社 新規トリプシン様酵素
JP3512486B2 (ja) 1994-09-27 2004-03-29 株式会社中埜酢店 しゃぶしゃぶ用濃縮胡麻垂れ

Also Published As

Publication number Publication date
AU1682399A (en) 1999-07-05
ES2263228T3 (es) 2006-12-01
CA2315218C (en) 2007-03-20
CN1222615C (zh) 2005-10-12
DE69834949T8 (de) 2008-10-09
DE69834949T2 (de) 2007-05-24
CA2315218A1 (en) 1999-06-24
DE69834949D1 (de) 2006-07-27
WO1999031271A1 (fr) 1999-06-24
EP1043406A1 (de) 2000-10-11
HK1032077A1 (en) 2001-07-06
KR20010033207A (ko) 2001-04-25
EP1043406B1 (de) 2006-06-14
JP4031199B2 (ja) 2008-01-09
EP1043406A4 (de) 2002-11-04
US6346385B1 (en) 2002-02-12
KR100502523B1 (ko) 2005-07-20
AU747991B2 (en) 2002-05-30
CN1285002A (zh) 2001-02-21

Similar Documents

Publication Publication Date Title
ATE330029T1 (de) Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease
Janoff Biochemical links between cigarette smoking and pulmonary emphysema
DK1984006T3 (da) Konditioneret blodsammensætning og fremgangsmåde til produktion deraf
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE444073T1 (de) Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten
ATE450622T1 (de) Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit
ATE286674T1 (de) Anordnung zum behandlen von krankheiten
Morice et al. Human ACE gene polymorphism and distilled water induced cough.
EP1474438A4 (de) Verfahren zur herstellung eines gereinigten rekombinanten humanen uteroglobins zur behandlung von entzündlichen und fibrotischen erkrankungen
WO2001004349A3 (en) Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
Fuschillo et al. Nocturnal mechanical ventilation improves exercise capacity in kyphoscoliotic patients with respiratory impairment.
Grilo et al. Genetic analysis of candidate SNPs for metabolic syndrome in obstructive sleep apnea (OSA)
Körber et al. Endotracheal complications after long-term ventilation. Noninvasive ventilation in chronic thoracic diseases as an alternative to tracheostomy
Alessi et al. Relation between plasma PAI activity and adipsin levels
WO1998031817A3 (en) Human lysosomal sialidase and therapeutic uses thereof
WO2002097127A3 (en) Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
WO2002010403A3 (en) Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
PL340624A1 (en) Preparations and drugs for treating chronic obstruction of respiratory tracts
Sandhaus Genetic Basis of Chronic Obstructive Pulmonary Disease
ATE374260T1 (de) Asthma-assoziiertes gen
ATE414789T1 (de) Marker für lungentumore
SU1672362A1 (ru) Способ прогнозировани прогрессирующего хронического воспалительного процесса в легких
Isobe et al. Antithrombin prevents stress-induced gastric mucosal injury by increasing the gastric prostacyclin level in rats
Bucholtz et al. The cystic fibrosis conductance regulator gene exon sequence is normal in a patient with edematous eosinophilic nasal polyps
Sapey et al. Neutrophils

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1043406

Country of ref document: EP